Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Apr;73(4):1237–1241. doi: 10.1172/JCI111311

Beta-endorphin inhibits glucose production in the conscious dog.

P M Radosevich, P E Williams, J R McRae, W W Lacy, D N Orth, N N Abumrad
PMCID: PMC425139  PMID: 6323537

Abstract

The effect of human beta-endorphin (h beta E) infusion (0.2 mg/h) on glucose homeostasis was studied in 10 conscious overnight fasted dogs in which endocrine pancreatic function was fixed at basal levels with somatostatin plus intraportal replacement of basal insulin and glucagon. h beta E caused a fall in plasma glucose from 107 +/- 5 to 76 +/- 6 mg/dl by 3 h (P less than 0.01). This was due to a 25% fall in tracer-determined glucose production (Ra; P less than 0.01). A significantly larger fall in Ra was observed in four dogs in which hypoglycemia was prevented by use of an exogenous glucose infusion (45 vs. 25%, P less than 0.05). These changes occurred in the absence of changes in circulating levels of insulin, glucagon, epinephrine, norepinephrine, and cortisol. We conclude that the naturally occurring opioid peptide, beta-endorphin, inhibits glucose production by the liver in vivo. This appears to be a direct effect of the opioid on the liver, since the inhibition took place in the absence of changes in the other hormones measured. These results suggest that endorphins act on glucose homeostasis in a complex way, both by affecting other glucoregulatory hormones as demonstrated elsewhere, and by directly modulating hepatic glucose production as shown here.

Full text

PDF
1237

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abumrad N. N., Cherrington A. D., Williams P. E., Lacy W. W., Rabin D. Absorption and disposition of a glucose load in the conscious dog. Am J Physiol. 1982 Jun;242(6):E398–E406. doi: 10.1152/ajpendo.1982.242.6.E398. [DOI] [PubMed] [Google Scholar]
  2. Abumrad N. N., Jefferson L. S., Rannels S. R., Williams P. E., Cherrington A. D., Lacy W. W. Role of insulin in the regulation of leucine kinetics in the conscious dog. J Clin Invest. 1982 Nov;70(5):1031–1041. doi: 10.1172/JCI110690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertagna X. Y., Stone W. J., Nicholson W. E., Mount C. D., Orth D. N. Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis. J Clin Invest. 1981 Jan;67(1):124–133. doi: 10.1172/JCI110004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cherrington A. D., Chiasson J. L., Liljenquist J. E., Lacy W. W., Park C. R. Control of hepatic glucose output by glucagon and insulin in the intact dog. Biochem Soc Symp. 1978;(43):31–45. [PubMed] [Google Scholar]
  5. Feldberg W., Shaligram S. V. The hyperglycaemic effect of morphine. Br J Pharmacol. 1972 Dec;46(4):602–618. doi: 10.1111/j.1476-5381.1972.tb06887.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Feldman M., Kiser R. S., Unger R. H., Li C. H. Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings. N Engl J Med. 1983 Feb 17;308(7):349–353. doi: 10.1056/NEJM198302173080701. [DOI] [PubMed] [Google Scholar]
  7. Green I. C., Perrin D., Pedley K. C., Leslie R. D., Pyke D. A. Effect of enkephalins and morphine on insulin secretion from isolated rat islets. Diabetologia. 1980 Aug;19(2):158–161. doi: 10.1007/BF00421864. [DOI] [PubMed] [Google Scholar]
  8. Houghten R. A., Swann R. W., Li C. H. beta-Endorphin: stability, clearance behavior, and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4588–4591. doi: 10.1073/pnas.77.8.4588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ipp E., Dhorajiwala J., Pugh W., Moossa A. R., Rubenstein A. H. Effects of an enkephalin analog on pancreatic endocrine function and glucose homeostasis in normal and diabetic dogs. Endocrinology. 1982 Dec;111(6):2110–2116. doi: 10.1210/endo-111-6-2110. [DOI] [PubMed] [Google Scholar]
  10. Ipp E., Dobbs R., Unger R. H. Morphine and beta-endorphin influence the secretion of the endocrine pancreas. Nature. 1978 Nov 9;276(5684):190–191. doi: 10.1038/276190a0. [DOI] [PubMed] [Google Scholar]
  11. Ipp E., Schusdziarra V., Harris V., Unger R. H. Morphine-induced hyperglycemia: role of insulin and glucagon. Endocrinology. 1980 Aug;107(2):461–463. doi: 10.1210/endo-107-2-461. [DOI] [PubMed] [Google Scholar]
  12. Kanter R. A., Ensinck J. W., Fujimoto W. Y. Disparate effects of enkephalin and morphine upon insulin and glucagon secretion by islet cell cultures. Diabetes. 1980 Jan;29(1):84–86. doi: 10.2337/diab.29.1.84. [DOI] [PubMed] [Google Scholar]
  13. Reid R. L., Yen S. S. beta-Endorphin stimulates the secretion of insulin and glucagon in humans. J Clin Endocrinol Metab. 1981 Mar;52(3):592–594. doi: 10.1210/jcem-52-3-592. [DOI] [PubMed] [Google Scholar]
  14. VASSALLE M. Role of catecholamine release in morphine hyperglycemia. Am J Physiol. 1961 Mar;200:530–534. doi: 10.1152/ajplegacy.1961.200.3.530. [DOI] [PubMed] [Google Scholar]
  15. van Loon G. H., Appel N. M. beta-Endorphin-induced hyperglycemia is mediated by increased central sympathetic outflow to adrenal medulla. Brain Res. 1981 Jan 5;204(1):236–241. doi: 10.1016/0006-8993(81)90671-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES